Nontyphoid salmonellae are widely spread in nature and are commonly associated with certain animals. In humans, nontyphoid Salmonella infections are most often associated with contaminated food products [1] . The major risk factors for nontyphoid salmonellosis and bacteremia are certain conditions that cause individuals to become immunocompromised [2] [3] [4] . The occurrence of nontyphoid Salmonella bacteremia is ominous and should prompt clinicians to consider whether an immunodeficiency is present.
Salmonella infection may manifest in 5 different clinical forms: an asymptomatic chronic carrier state, gastroenteritis, enteric fever, bacteremia, and extraintestinal localized complications [5] . In immunocompromised hosts, nontyphoid salmonellosis can result in bacteremia and endovascular infection, leading to a high mortality rate [6, 7] . We have reported that, in Taiwan, the incidence of endovascular infection among adult patients with nontyphoid salmonellosis was high [8] . Old age and infection with group C Salmonella organisms predispose patients to acquire endovascular infection [9] . In recent decades, the number of infections due to antimicrobial-resistant Salmonella organisms has increased [10, 11] . Whether antimicrobial resistance contributes to endovascular infection is unclear. Limited data on the association of antimicrobial resistance with clinical features of nontyphoid salmonellosis have been reported [12, 13] . The present study sought to define the role of antimicrobial resistance in patients infected with group C nontyphoid salmonellae.
Patients and methods. National Taiwan University Hospital (Taipei, Taiwan, Republic of China) is a 2000-bed tertiary care hospital. With both first-line and tertiary facilities, it serves an urban population of 2 million persons. It also serves as a referral center for other hospitals in the seat of the Republic of China, which has a population of 22 million persons.
A retrospective analysis of the clinical and bacteriological data for all adult patients (age, у18 years) with infection due to group C nontyphoid salmonellae from January 2000 through September 2004 was performed. Patients were included in the present study if they had at least 1 blood or stool culture result that was positive for group C nontyphoid salmonellae. The medical records of the patients were reviewed, and data on demographic characteristics (age and sex), underlying disease (diabetes mellitus, liver cirrhosis, systemic lupus erythematosus, hematologic malignancy, and solid-organ cancer), bacteriological findings (detection of Salmonella serogroups A-E and G), antimicrobial resistance, and in-hospital outcome of infection (survival or death) were recorded.
"Immunodeficiency" was defined by the presence of HIV infection or by suppression of the immune system that occurred with receipt of steroid therapy, chemotherapy for malignancy, or immunosuppressive therapy for organ transplantation. "Endovascular infection" was defined as infective endocarditis or an infected aortic aneurysm documented by an imaging study or a tissue culture [9] .
Salmonella isolates were initially identified by biochemical tests. Serogroup determination was done by agglutination testing with the use of antisera specific to the O antigen. Testing of the bacterial isolates for susceptibility to antimicrobial drugs was performed using the disk diffusion method, as described by the NCCLS [14] . For the current report, we presented only susceptibility data for ampicillin, chloramphenicol, ciprofloxacin, trimethoprim-sulfamethoxazole, and cefotaxime. Results. A total of 54 patients with infection due to group C nontyphoid salmonellae were evaluated during the study period. Of these patients, 8 had gastroenteritis and 46 had bacteremia. Twelve patients with bacteremia had endovascular infections (1 had infective endocarditis, and 11 had an infected aortic aneurysm). The patient group included 31 men and 23 women; the median patient age was 51.5 years (range, 18-89 years). Medical comorbidities included uremia (2 patients), liver cirrhosis (4 patients), diabetes mellitus (3 patients), systemic lupus erythematosus (5 patients), hematologic malignancies (8 patients), and solid-organ cancers (9 patients). A total of 22 patients (41%) had an immunodeficiency; the immunodeficiency was due to HIV infection (8 patients), steroid therapy (8 patients), and/or chemotherapy (10 patients). Four patients had у2 factors for immunodeficiency.
Of the 54 Salmonella isolates recovered, 43 (80%) were ampicillin resistant, 47 (87%) were chloramphenicol resistant, 33 (61%) were ciprofloxacin resistant, 34 (63%) were trimethoprim-sulfamethoxazole resistant, and none was cefotaxime resistant. As shown in table 1, the incidence of ciprofloxacin resistance among the isolates significantly increased (from 11 The in-hospital mortality rate was 0% for patients with gastroenteritis and 30% for patients with bacteremia. For 46 patients with bacteremia, the in-hospital mortality rate did not differ between patients infected with ciprofloxacin-resistant Salmonella organisms (10 [30%] of 33 patients) and those infected with ciprofloxacin-susceptible Salmonella organisms (4 [31%] of 13 patients). Of 46 patients with bacteremia, 12 (26%) had endovascular infection. Table 2 shows the demographic, clinical, and antimicrobial-resistance data for patients who had endovascular infection and patients who did not. Patients with endovascular infection were old, had less immunodeficiency, and had fewer infections with ciprofloxacin-resistant Salmonella organisms, compared with patients who did not have endovascular infection. By use of a logistic regression model, the independent positive predictor for endovascular infection was old age (OR, 1.08; 95% CI, 1.02-1.14;
), and the negative predictor P p .008 was ciprofloxacin resistance (OR, 0.09; 95% CI, 0.02-0.58;
). P p .011
Discussion. Endovascular infection is an important complication that is difficult to treat. A review of 140 patients with a Salmonella-infected aortic aneurysm found a mortality rate of 60% [6] . Previous studies performed in Western countries found that ∼10% of adults with bacteremia who were 150 years of age developed endovascular infection [3, 15, 16] . In a recent report from Spain, the risk of endovascular infection in patients with bacteremia who were 160 years of age was 23% [17] . The incidence of endovascular infection is also high in Taiwan [8, 9, 18] . In the present study, 12 (26%) of 46 patients with nontyphoid Salmonella bacteremia had endovascular infection. However, this incidence is probably overestimated because of referral bias.
Patients with immunodeficiency are thought to be susceptible to endovascular infection due to Salmonella organisms. Cohen et al. [15] reported that persons 150 years of age who have Salmonella bacteremia and clinical evidence of infection before hospitalization appear to have a high risk for endovascular infection. We have reported elsewhere [9] that old age and the presence of group C Salmonella organisms are risk factors for endovascular infection. Group C Salmonella organisms account for !25% of cases of Salmonella-infected aortic aneurysm in Western countries [7] ; however, in Taiwan, the most common causative pathogens in patients with endovascular infection are group C and group D Salmonella organisms. Antimicrobial-resistant nontyphoid Salmonella organisms are increasingly common and appear with variable geographical incidence [10, 11] . In Taiwan, 140% of clinical isolates of nontyphoid Salmonella species were resistant to multiple antimi- crobials [19] . Chiu et al. [20] reported that Salmonella enterica serotype Choleraesuis is the most common pathogen (incidence, 74%) among group C Salmonella organisms in Taiwan.
Resistance to ciprofloxacin has been observed in S. Choleraesuis since 2000, and, in 2001, a total of 60% of such isolates were resistant to ciprofloxacin [21] . Antimicrobial-resistant Salmonella organisms can spread from animal to humans. In Taiwan, pigs were considered to be a potential source of invasive Salmonella organisms [21] [22] [23] . The use of antimicrobials in food animals contributes to the increased incidence of ciprofloxacin resistance among group C Salmonella organisms [21, 22] . In the present study, we selected patients with infection due to group C salmonellae because of the propensity of such organisms to cause endovascular infection [9] and to have a high incidence of antimicrobial (i.e., fluoroquinolone) resistance [19, 21, 23, 24] . In the present study, the incidence of ciprofloxacin resistance among group C Salmonella organisms significantly increased from 42% in 2000-2002 to 79% in 2003-2004 . Several studies have addressed the clinical association between antimicrobial resistance and the virulence of nontyphoid Salmonella organisms. Patients with infection caused by antimicrobial-resistant organisms are significantly more likely to be hospitalized and be ill for a longer time than are patients with infections due to antimicrobial-susceptible organisms [12] . Helms et al. [13] reported an increase in the mortality rate associated with antimicrobial-resistant S. enterica serotype Typhimurium. In the present study, patients with bacteremia had more cases of infection due to Salmonella organisms that were resistant to ampicillin, chloramphenicol, ciprofloxacin, and trimethoprim-sulfamethoxazole. The Salmonella isolates recovered from patients with gastroenteritis were all ciprofloxacin susceptible. Ciprofloxacin resistance has no influence on in-hospital mortality among patients with bacteremia and is the negative predictor of endovascular infection. We conclude that, although ciprofloxacin-resistant Salmonella organisms predispose patients to acquire bacteremia, they do not seem to predispose patients to acquire endovascular infection. Antimicrobial resistance may be associated with a change in the virulence of the strain [25] .
The major limitation of the present study is the lack of Salmonella serotype determination and the lack of detailed antimicrobial-resistance testing. In addition, National Taiwan University Hospital is a referral institution. The patients who were referred to this hospital were more likely to have developed bacteremia and endovascular infection.
In conclusion, there are increasing numbers of infections due to ciprofloxacin-resistant Salmonella organisms. Ciprofloxacinresistant Salmonella organisms predispose patients to acquire bacteremia, but they did not seem to predispose patients to acquire endovascular infection.
